As funders we strive to support research of the highest scientific and ethical quality that will advance knowledge and its application to deliver benefit to the public. We recognise, however, that there is a risk that the results of some types of research could also potentially be misused to cause great harm.
This joint policy statement from the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC) and the Wellcome Trust sets out a shared approach to managing risks, and describes how we think the broader research community should play their part.
The Department for Science, Innovation and Technology (DSIT) has published guidance on screening synthetic nucleic acids for individuals and organisations involved in their provision, use, and transfer within the UK. The guidance sets baseline expectations, supports biosecurity measures, and aligns with the UK’s commitment to responsible innovation in engineering biology. Read the full guidance here: UK screening guidance on synthetic nucleic acids for users and providers – GOV.UK.
Contact
Email: bbsrc.inquiries@bbsrc.ukri.org
Last updated: 19 March 2025